These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33621628)

  • 1. Role of pulmonary arterial capacitance in predicting mortality in patients with pulmonary hypertension: A systematic review and meta-analysis.
    Rajdev K; Lahan S; Wichman T
    Int J Cardiol; 2021 Jun; 333():202-209. PubMed ID: 33621628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease.
    Sugimoto K; Yoshihisa A; Nakazato K; Jin Y; Suzuki S; Yokokawa T; Misaka T; Yamaki T; Kunii H; Suzuki H; Saitoh SI; Takeishi Y
    PLoS One; 2016; 11(11):e0165603. PubMed ID: 27875533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension.
    Dragu R; Rispler S; Habib M; Sholy H; Hammerman H; Galie N; Aronson D
    Eur J Heart Fail; 2015 Jan; 17(1):74-80. PubMed ID: 25388783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary artery compliance in different forms of pulmonary hypertension.
    McCormick A; Krishnan A; Badesch D; Benza RL; Bull TM; De Marco T; Feldman J; Hemnes AR; Hirsch R; Horn E; Kennedy J; Mathai SC; McConnell W; Pugliese SC; Sager JS; Shlobin OA; Simon MA; Lammi MR
    Heart; 2023 Jun; 109(14):1098-1105. PubMed ID: 36787969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of Pulmonary Arterial Compliance in Systemic Lupus Erythematosus Patients With Pulmonary Arterial Hypertension.
    Guo X; Lai J; Wang H; Tian Z; Zhao J; Li M; Fang Q; Fang L; Liu Y; Zeng X
    Hypertension; 2020 Oct; 76(4):1161-1168. PubMed ID: 32772648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection Fraction.
    Al-Naamani N; Preston IR; Paulus JK; Hill NS; Roberts KE
    JACC Heart Fail; 2015 Jun; 3(6):467-474. PubMed ID: 26046840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Preoperative Pulmonary Arterial Capacitance for Patients Undergoing Aortic Valve Replacement for Severe Aortic Valve Stenosis.
    Yamashita K; Abe T; Hayata Y; Hirose T; Taniguchi S
    Circ J; 2019 Oct; 83(11):2222-2228. PubMed ID: 31484840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis.
    Farmakis IT; Vazakidis P; Doundoulakis I; Arvanitaki A; Zafeiropoulos S; Boutou A; Karvounis H; Giannakoulas G
    Pulm Pharmacol Ther; 2021 Jun; 68():102036. PubMed ID: 33979684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal change in pulmonary arterial capacitance as an indicator of prognosis and response to therapy and in pulmonary arterial hypertension.
    Medrek SK; Kloefkorn C; Nguyen DTM; Graviss EA; Frost AE; Safdar Z
    Pulm Circ; 2017; 7(2):399-408. PubMed ID: 28597758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Pulmonary Arterial Capacitance Calculated by Echocardiography in Patients With Advanced Heart Failure.
    Saito Y; Ohtani T; Kioka H; Onishi T; Tsukamoto Y; Nakamoto K; Taniguchi T; Nakatani S; Hirayama A; Sakata Y
    Circ J; 2017 Nov; 81(12):1871-1878. PubMed ID: 28679970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy.
    Kearney K; Brown K; Celermajer DS; Collins N; Cordina R; Corrigan C; Dwyer N; Feenstra J; Keating D; Keogh A; Kotlyar E; Lavender M; McWilliams T; Williams T; Whitford H; Weintraub R; Wrobel J; Ellender C; Anderson J; Lau EM;
    Chest; 2024 Apr; 165(4):967-977. PubMed ID: 37951349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic assessment of pulmonary arterial capacitance predicts mortality in pulmonary hypertension.
    Papolos A; Tison GH; Mayfield J; Vasti E; DeMarco T
    J Cardiol; 2021 Mar; 77(3):279-284. PubMed ID: 33158713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diastolic Pressure Difference to Classify Pulmonary Hypertension in the Assessment of Heart Transplant Candidates.
    Wright SP; Moayedi Y; Foroutan F; Agarwal S; Paradero G; Alba AC; Baumwol J; Mak S
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary arterial capacitance predicts outcomes in patients with pulmonary hypertension independent of race/ethnicity, sex, and etiology.
    Mayfield JJ; Papolos A; Vasti E; De Marco T; Tison GH
    Respir Med; 2020 Mar; 163():105891. PubMed ID: 32056840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why there is a need to discuss pulmonary hypertension other than pulmonary arterial hypertension?
    Papathanasiou A; Nakos G
    World J Crit Care Med; 2015 Nov; 4(4):274-7. PubMed ID: 26557477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension associated with left heart disease.
    Adir Y; Amir O
    Semin Respir Crit Care Med; 2013 Oct; 34(5):665-80. PubMed ID: 24037633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review.
    Kido K; Coons JC
    Pharmacotherapy; 2019 Sep; 39(9):929-945. PubMed ID: 31349390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
    Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
    Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.